Annual EBITDA
$20.33 M
+$9.99 M+96.74%
December 31, 2023
Summary
- As of February 7, 2025, GYRE annual EBITDA is $20.33 million, with the most recent change of +$9.99 million (+96.74%) on December 31, 2023.
- During the last 3 years, GYRE annual EBITDA has fallen by -$11.33 million (-35.79%).
- GYRE annual EBITDA is now -35.79% below its all-time high of $31.66 million, reached on December 1, 2021.
Performance
GYRE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$4.69 M
+$1.19 M+33.91%
September 30, 2024
Summary
- As of February 7, 2025, GYRE quarterly EBITDA is $4.69 million, with the most recent change of +$1.19 million (+33.91%) on September 30, 2024.
- Over the past year, GYRE quarterly EBITDA has increased by +$9.57 million (+196.03%).
- GYRE quarterly EBITDA is now -63.85% below its all-time high of $12.97 million, reached on September 1, 2023.
Performance
GYRE Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
$11.80 M
-$8.28 M-41.23%
September 30, 2024
Summary
- As of February 7, 2025, GYRE TTM EBITDA is $11.80 million, with the most recent change of -$8.28 million (-41.23%) on September 30, 2024.
- Over the past year, GYRE TTM EBITDA has dropped by -$8.53 million (-41.94%).
- GYRE TTM EBITDA is now -53.18% below its all-time high of $25.21 million, reached on September 1, 2023.
Performance
GYRE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
GYRE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +96.7% | +196.0% | -41.9% |
| 3 y3 years | -35.8% | -32.6% | +69.8% |
| 5 y5 years | -35.8% | -32.6% | +69.8% |
GYRE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -35.8% | +96.7% | -63.9% | +196.0% | -53.2% | +69.8% |
| 5 y | 5-year | -35.8% | +96.7% | -63.9% | +196.0% | -53.2% | +69.8% |
| alltime | all time | -35.8% | +96.7% | -63.9% | +196.0% | -53.2% | +69.8% |
Gyre Therapeutics EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $4.69 M(+33.9%) | $11.80 M(-41.2%) |
| Jun 2024 | - | $3.50 M(-58.8%) | $20.08 M(-8.2%) |
| Mar 2024 | - | $8.50 M(-274.1%) | $21.87 M(+7.6%) |
| Dec 2023 | $20.33 M | -$4.88 M(-137.6%) | $20.33 M(-19.4%) |
| Sep 2023 | - | $12.97 M(+145.0%) | $25.21 M(+105.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2023 | - | $5.29 M(-23.9%) | $12.24 M(+76.1%) |
| Mar 2023 | - | $6.95 M(-17.6%) | $6.95 M(-17.6%) |
| Dec 2022 | $10.33 M(-67.4%) | - | - |
| Mar 2022 | - | $8.43 M | $8.43 M |
| Dec 2021 | $31.66 M | - | - |
FAQ
- What is Gyre Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Gyre Therapeutics?
- What is Gyre Therapeutics annual EBITDA year-on-year change?
- What is Gyre Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Gyre Therapeutics?
- What is Gyre Therapeutics quarterly EBITDA year-on-year change?
- What is Gyre Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Gyre Therapeutics?
- What is Gyre Therapeutics TTM EBITDA year-on-year change?
What is Gyre Therapeutics annual EBITDA?
The current annual EBITDA of GYRE is $20.33 M
What is the all time high annual EBITDA for Gyre Therapeutics?
Gyre Therapeutics all-time high annual EBITDA is $31.66 M
What is Gyre Therapeutics annual EBITDA year-on-year change?
Over the past year, GYRE annual EBITDA has changed by +$9.99 M (+96.74%)
What is Gyre Therapeutics quarterly EBITDA?
The current quarterly EBITDA of GYRE is $4.69 M
What is the all time high quarterly EBITDA for Gyre Therapeutics?
Gyre Therapeutics all-time high quarterly EBITDA is $12.97 M
What is Gyre Therapeutics quarterly EBITDA year-on-year change?
Over the past year, GYRE quarterly EBITDA has changed by +$9.57 M (+196.03%)
What is Gyre Therapeutics TTM EBITDA?
The current TTM EBITDA of GYRE is $11.80 M
What is the all time high TTM EBITDA for Gyre Therapeutics?
Gyre Therapeutics all-time high TTM EBITDA is $25.21 M
What is Gyre Therapeutics TTM EBITDA year-on-year change?
Over the past year, GYRE TTM EBITDA has changed by -$8.53 M (-41.94%)